IP Library › Assignment 039254/0828
Patent Assignment
Reel/Frame 039254/0828

Security Interest

Recorded: 2016-07-05 Pages: 26
Assignor
FORUM PHARMACEUTICALS INC.
Executed: 2016-05-23
Assignee
FMR LLC
155 SEAPORT BLVD., BOSTON, MASSACHUSETTS, 02210
Covered Properties (62)
Inhibitors of Histone Deacetylase
1, 2 Disubstituted Heterocyclic Compounds
Phenoxymethyl Heterocyclic Compounds
Imidazotriazinone Compounds
Imidazotriazinone Compounds
Polymorphs and Salts of a Compound
Fused Morphlinopyrimidines and Methods of Use Thereof
Fused Morpholinopyrimidines and Methods of Use Thereof
Fused Morpholinopyrimidines and Methods of Use Thereof
2-Heteroarylcarboxylic Acid Amides
Patent: 7,732,477 →
Application: 10/500,096 →
Publication: US 2005/0119325
Dibenzo[B,F][1,4]Oxazepin-11-Yl-N-Hydroxybenzamides as Hdac Inhibitors
Patent: 8,399,452 →
Application: 11/925,151 →
Publication: US 2008/0207590
1,2-Disubstituted Heterocyclic Compounds
Patent: 8,071,595 →
Application: 12/490,808 →
Publication: US 2010/0137317
Phenoxymethyl Heterocyclic Compounds
Patent: 8,343,973 →
Application: 12/642,026 →
Publication: US 2010/0292238
2-Heteroarylcarboxylic Acid Amides
Patent: 8,076,355 →
Application: 12/777,764 →
Publication: US 2010/0222378
Methods for Treating Cognitive Disorders Using Inhibitors of Histone Deacetylase
Application: 12/991,095 →
Publication: US 2011/0288070
5- and 6-Membered Heterocyclic Compounds
Patent: 8,481,534 →
Application: 13/001,359 →
Publication: US 2011/0183976
Inhibitors of Histone Deacetylase
Application: 13/079,458 →
Publication: US 2011/0196147
Treatment of Cognitive Disorders with (R)-7-Chloro-N-(Quinuclidin-3-Yl)Benzo[B]Thiophene-2-Carboxamide and Pharmaceuticall Acceptable Salts Thereof
Patent: 8,642,638 →
Application: 13/129,782 →
Publication: US 2011/0288119
2-Heteroarylcarboxylic Acid Amides
Patent: 8,884,017 →
Application: 13/289,346 →
Publication: US 2012/0202842
1,2-Disubstituted Heterocyclic Compounds
Patent: 8,466,148 →
Application: 13/290,527 →
Publication: US 2012/0232265
Treatment of Cognitive Disorders with (R)-7-Chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-Carboxamide and Pharmaceutically Acceptable Salts Thereof
Patent: 8,569,354 →
Application: 13/674,290 →
Publication: US 2013/0137717
Crystalline Form of (R)-7-Chloro-N-(Quinuclidin-3-Yl)Benzo[B]Thiophene-2-Carboxamide Hydrochloride Monohydrate
Patent: 8,710,227 →
Application: 13/698,759 →
Publication: US 2013/0183380
Phenoxymethyl Heterocyclic Compounds
Patent: 8,946,222 →
Application: 13/722,595 →
Publication: US 2013/0143888
Dibenzo[B,F][1,4]Oxazepin-11-yl-N-Hydroxybenzamides as HDAC Inhibitors
Patent: 9,193,749 →
Application: 13/767,478 →
Publication: US 2014/0011988
1,2-Disubstituted Heterocyclic Compounds
Patent: 8,933,074 →
Application: 13/919,320 →
Publication: US 2014/0011808
Methods of Targeted Treatment of Frontotemporal Lobar Degeneration
Application: 14/007,572 →
Publication: US 2014/0179678
Treatment of Cognitive Disorders with (R)-7-Chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-Carboxamide and Pharmaceutically Acceptable Salts Thereof
Application: 14/139,178 →
Publication: US 2014/0148479
Treatment of Cognitive Disorders with (R)-7-Chloro-N-(Quinuclidin-3-Yl)Benzo[B]Thiophene-2-Carboxamide and Pharmaceutically Acceptable Salts Thereof
Patent: 8,815,933 →
Application: 14/175,654 →
Publication: US 2014/0155430
Crystalline Form of (R)-7-Chloro-N-(Quinuclidin-3-YL)benzo[B]thiophene-2-Carboxamide Hydrochloride Monohydrate
Patent: 9,108,961 →
Application: 14/184,453 →
Publication: US 2014/0249179
Methods for Treating Cognitive Disorders Using Inhibitors of Histone Deacetylase
Application: 14/242,405 →
Publication: US 2015/0080325
Imidazotriazinone Compounds
Patent: 9,540,380 →
Application: 14/334,073 →
Publication: US 2014/0330014
Methods of Maintaining, Treating or Improving Cognitive Function
Patent: 9,585,877 →
Application: 14/399,809 →
Publication: US 2015/0126547
Imidazotriazinone Compounds
Patent: 9,725,453 →
Application: 14/490,036 →
Publication: US 2015/0191476
Treatment of Cognitive Disorders with (R)-7-Chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-Carboxamide and Pharmaceutically Acceptable Salts Thereof
Application: 14/509,305 →
Publication: US 2015/0265583
1,2-Disubstituted Heterocyclic Compounds
Patent: 9,265,767 →
Application: 14/529,435 →
Publication: US 2015/0274706
Phenoxymethyl Heterocyclic Compounds
Application: 14/564,507 →
Publication: US 2015/0322069
5- and 6-Membered Heterocyclic Compounds
Application: 14/576,550 →
Publication: US 2015/0344467
Crystalline Form of (R)-7-Chloro-N-(Quinuclidin-3-Yl)Benzo[B]Thiophene-2-Carboxamide Hydrochloride Monohydrate
Patent: 9,273,044 →
Application: 14/795,595 →
Publication: US 2016/0009707
Polymorphs and Salts of a Compound
Application: 14/851,250 →
Publication: US 2016/0002250
Dibenzo[B,F][1,4]oxazepin-11-yl-N-Hydroxybenzamides as HDAC Inhibitors
Application: 14/853,222 →
Publication: US 2016/0222026
Treatment of Cognitive Disorders with (R)-7-Chloro-N-(Quinuclidin-3-YL)benzo[B]thiophene-2-Carboxamide and Pharmaceutically Acceptable Salts Thereof
Application: 14/979,289 →
Crystalline Form of (R)-7-Chloro-N-(Quinuclidin-3-YL)benzo[B]thiophene-2-Carboxamide Hydrochloride Monohydrate
Patent: 9,550,767 →
Application: 15/002,163 →
Publication: US 2016/0137638
Methods for Treating Cognitive Disorders Using Inhibitors of Histone Deacetylase
Application: 15/016,126 →
Publication: US 2017/0000749
Inhibitors of Histone Deacetylase
Application: 60/863,347 →
Inhibitors of Histone Deacetylase
Application: 60/884,287 →
Methods for Treating Cognitive Disorders Using Inhibitors of Histone Deacetylase
Application: 61/050,545 →
Treatment of Cognitive Disorders with (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide
Application: 61/116,106 →
Crystalline Form of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate
Application: 61/345,363 →
Crystalline Form of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate
Application: 61/352,092 →
Imidazotriazinone Compounds
Application: 61/612,866 →
Mentor-Tuned Guided Learning in Online Educational Systems
Application: 61/647,989 →
Methods of Maintaining, Treating or Improving Cognitive Function
Application: 61/670,087 →
Aminobenzisoxazole Compounds as Agonists of Alpha-7-Nicotinic Acetylcholine Receptors
Application: 62/173,717 →
Oxadiazine Compounds and Methods of Use Thereof
Application: 62/173,723 →
Geminal-Substituted Aminobenzisoxazole Compounds as Agonists of Alpha-7-Nicotinic Acetylcholine Receptors
Application: 62/204,230 →
Oxadiazines and Methods of Use Thereof
Application: 62/206,577 →
Aminoisoxazoline Compounds as Agonists of Alpha-7-Nicotinic Acetylcholine Receptors
Application: 62/243,947 →
Phosphodiesterase 9 Inhibitor and Levodopa Therapy
Application: 62/243,968 →
Phosphodiesterase 9 Inhibitor and Levodopa Therapy
Application: 62/247,882 →
Oxadiazine Compounds and Methods of Use Thereof
Application: 62/279,384 →
Oxadiazine Compounds and Methods of Use Thereof
Application: 62/279,391 →
Oxadiazine Compounds and Methods of Use Thereof
Application: 62/311,228 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 7, 2005
From: HENDRIX, MARTIN; BOSS, FRANK-GERHARD; ERB, CHRISTINA; FLESSNER, TIMO
To: BAYER HEALTHCARE AG
Reel/Frame 015539/0309 →
Assignment of Assignor's Interest Apr 16, 2008
From: DEZIEL, ROBERT; LEIT, SILVANA; BEAULIEU, PATRICK; CHANTIGNY, YVES ANDRE
To: METHYLGENE INC.
Reel/Frame 020814/0357 →
Assignment of Assignor's Interest Apr 16, 2008
From: SHAPIRO, GIDEON; CHESWORTH, RICHARD
To: ENVIVO PHARMACEUTICALS
Reel/Frame 020814/0371 →
Merger Jan 12, 2010
From: BAYER HEALTHCARE AG
To: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
Reel/Frame 023769/0122 →
Assignment of Assignor's Interest Apr 9, 2010
From: RIPKA, AMY; SHAPIRO, GIDEON; CHESWORTH, RICHARD
To: ENVIVO PHARMACEUTICALS, INC.
Reel/Frame 024211/0601 →
Assignment of Assignor's Interest Apr 12, 2010
From: RIPKA, AMY; SHAPIRO, GIDEON; CHESWORTH, RICHARD
To: ENVIVO PHARMACEUTICALS, INC.
Reel/Frame 024215/0082 →
Assignment of Assignor's Interest Jun 29, 2010
From: RIPKA, AMY; SHAPIRO, GIDEON; CHESWORTH, RICHARD
To: ENVIVO PHARMACEUTICALS, INC.
Reel/Frame 024624/0581 →
Assignment of Assignor's Interest Apr 5, 2011
From: RIPKA, AMY; SHAPIRO, GIDEON; CHESWORTH, RICHARD
To: ENVIVO PHARMACEUTICALS, INC.
Reel/Frame 026075/0075 →
Assignment of Assignor's Interest Aug 9, 2011
From: ROGERS, KATHRYN; PATZKE, HOLGER
To: ENVIVO PHARMACEUTICALS, INC.
Reel/Frame 026723/0012 →
Assignment of Assignor's Interest Aug 9, 2011
From: CHESWORTH, RICHARD; SHAPIRO, GIDEON; KOENIG, GERHARD
To: ENVIVO PHARMACEUTICALS, INC.
Reel/Frame 026721/0035 →
Assignment of Assignor's Interest Nov 12, 2012
From: CHESWORTH, RICHARD; SHAPIRO, GIDEON; KOENIG, GERHARD
To: ENVIVO PHARMACEUTICALS, INC.
Reel/Frame 029279/0776 →
Assignment of Assignor's Interest Mar 1, 2013
From: BAYER PHARMA AKTIENGESELLSCHAFT
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 029908/0217 →
Assignment of Assignor's Interest Apr 3, 2013
From: KISHIDA, MUNEKI; ISHIGE, TAKAYUKI
To: MITSUBISHI TANABE PHARMA CORPORATION
Reel/Frame 030143/0512 →
Assignment of Assignor's Interest Apr 3, 2013
From: OLIVER-SHAFFER, PATRICIA; SHAPIRO, GIDEON; CHESWORTH, RICHARD
To: ENVIVO PHARMACEUTICALS, INC.
Reel/Frame 030143/0440 →
Assignment of Assignor's Interest Apr 3, 2013
From: MITSUBISHI TANABE PHARMA CORPORATION
To: ENVIVO PHARMACEUTICALS, INC.
Reel/Frame 030143/0621 →
Change of Name Apr 12, 2013
From: BAYER SCHERING PHARMA AG
To: BAYER PHARMA AKTIENGESELLSCHAFT
Reel/Frame 030202/0001 →
Assignment of Assignor's Interest Mar 5, 2014
From: DEZIEL, ROBERT; LEIT, SILVANNA; BEAULIEU, PATRICK; CHANTIGNY, YVES ANDRE
To: METHYLGENE INC.
Reel/Frame 032356/0479 →
Assignment of Assignor's Interest Mar 5, 2014
From: SHAPIRO, GIDEON; CHESWORTH, RICHARD
To: ENVIVO PHARMACEUTICALS
Reel/Frame 032356/0327 →
Change of Name Apr 21, 2014
From: ENVIVO PHARMACEUTICALS, INC.
To: FORUM PHARMACEUTICALS, INC.
Reel/Frame 032722/0659 →
Change of Name May 23, 2014
From: ENVIVO PHARMACEUTICALS, INC.
To: FORUM PHARMACEUTICALS INC.
Reel/Frame 033015/0990 →
Assignment of Assignor's Interest May 23, 2014
From: RIPKA, AMY; SHAPIRO, GIDEON; CHESWORTH, RICHARD
To: ENVIVO PHARMACEUTICALS, INC.
Reel/Frame 032958/0715 →
Change of Name May 23, 2014
From: ENVIVO PHARMACEUTICALS, INC.
To: FORUM PHARMACEUTICALS INC.
Reel/Frame 033015/0930 →
Change of Name May 23, 2014
From: ENVIVO PHARMACEUTICALS, INC.
To: FORUM PHARMACEUTICALS INC.
Reel/Frame 033015/0883 →
Change of Name Jun 3, 2014
From: ENVIVO PHARMACEUTICALS, INC.
To: FORUM PHARMACEUTICALS INC.
Reel/Frame 033080/0454 →
Assignment of Assignor's Interest Jun 3, 2014
From: RIPKA, AMY; SHAPIRO, GIDEON; CHESWORTH, RICHARD
To: ENVIVO PHARMACEUTICALS, INC.
Reel/Frame 033017/0099 →